Michael J. Eppihimer

Showing 1-3 of 3 articles

Impact of bioresorbable versus permanent polymer on long-term vessel wall inflammation and healing: a comparative drug-eluting stent experimental study

Wilson G, McGregor J, Conditt G, Shibuya M, Sushkova N, Eppihimer M, Hawley S, Rousselle S, Huibregtse B, Dawkins K, Granada J

February 20, 2018 | 10.4244/EIJ-D-17-00332

Peripheral interventions

Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model

Hou D, Huibregtse B, Eppihimer M, Stoffregen W, Kocur G, Hitzman C, Stejskal E, Heil J, Dawkins K

August 20, 2016 | 10.4244/EIJV12I6A128

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen J, King III S, Chronos N, Eppihimer M, Huibregtse B, Dawkins K, Hou D

August 24, 2012 | 10.4244/EIJV8I4A77

1

Latest news

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?

Michael Foley et al.

September 20, 2021

Valvular disease